Why Ketamine Works When 2+ Antidepressants Have Failed

You've done everything your doctors asked. You took the first antidepressant faithfully for six weeks and felt nothing change. You tried a second, maybe a third or fourth, each time enduring the side effects, the waiting, and the slow disappointment. You've adjusted doses, combined medications, maybe added therapy. The weight is still there.

If this is your story, what you're experiencing has a name. It's treatment-resistant depression, and it affects roughly one in three people with major depressive disorder. Your experience is also telling you something important about your particular biology: your depression likely operates through neural pathways that serotonin-based medications don't adequately reach.

This is where ketamine enters the picture, and it's worth saying clearly that it's not a last resort. It's a treatment specifically suited to the neurobiology that standard antidepressants miss.

The Fundamental Difference: Glutamate vs. Serotonin

To understand why ketamine can work when SSRIs and SNRIs have failed, you have to understand that these treatments are targeting entirely different systems in the brain.

How SSRIs and SNRIs work

Conventional antidepressants focus on the monoamine neurotransmitters, primarily serotonin (and in the case of SNRIs, norepinephrine). They block the reabsorption of these chemicals, which increases their availability between neurons. The approach helps many people, but it operates on a theory of depression (the monoamine hypothesis) that we now know is incomplete.

How ketamine works

Ketamine works through the glutamate system, the brain's primary excitatory neurotransmitter network, which is far more extensive than the serotonin system. Specifically, ketamine is an NMDA receptor antagonist. By temporarily blocking NMDA receptors, it triggers a cascade of downstream effects that are fundamentally different from anything SSRIs can accomplish.

AMPA receptor activation increases, leading to a surge of glutamate signaling through alternative pathways. The release of brain-derived neurotrophic factor (sometimes called "fertilizer for the brain" because of its role in neuronal growth and survival) is stimulated. The mTOR signaling pathway gets activated, which drives the formation of new synaptic connections. And synaptic density increases in key brain regions, particularly the prefrontal cortex.

In plainer terms: while SSRIs try to make better use of the serotonin you have, ketamine helps your brain grow new connections and repair damaged neural circuitry. For the deeper neurobiology, see How Ketamine Works for Treatment-Resistant Depression: The BDNF/mTOR Story or the plain-language overview at How Does Ketamine Work for Depression.

BDNF and Neuroplasticity: Rebuilding What Depression Broke

One of the most consequential discoveries in depression research over the past two decades is that chronic depression causes measurable structural damage to the brain. Neuroimaging studies show reduced volume in the prefrontal cortex and hippocampus, and decreased synaptic density. The connections between neurons literally wither.

That synaptic atrophy helps explain why depression feels so immovable. It is not just a chemical imbalance; it's a structural one. Restoring structure requires more than adjusting neurotransmitter levels. It requires neuroplasticity: the brain's ability to form new connections and pathways.

This is where ketamine's effect on BDNF becomes important. BDNF levels are consistently found to be lower in people with depression, especially treatment-resistant depression. Ketamine rapidly increases BDNF expression, often within hours of administration. Higher post-treatment BDNF levels correlate with greater symptom improvement, which suggests this mechanism is directly tied to clinical outcomes. And the new synaptic connections formed through BDNF-driven neuroplasticity may help explain the sustained benefits some patients experience well beyond the drug's immediate effects.

SSRIs may modestly increase BDNF over time (which could partially explain their delayed onset), but ketamine's effect on this pathway is far more rapid and pronounced.

Rapid Onset: Hours Instead of Weeks

Perhaps the most striking clinical difference between ketamine and conventional antidepressants is speed. SSRIs and SNRIs typically require four to eight weeks to show full effects, and during that waiting period patients continue to suffer. In severe cases, the delay can be dangerous. Ketamine can produce noticeable improvements in mood and suicidal ideation within hours to days of the first treatment.

The rapid onset isn't just a convenience. For individuals with severe depression and active suicidal thoughts, weeks of waiting for a medication to possibly work is an unacceptable timeline. Ketamine's ability to provide quick relief fills a critical gap that has existed in psychiatry for decades. (See our dedicated piece on ketamine for suicidal ideation for the research on this specifically.)

Why is ketamine so much faster?

The speed difference comes back to mechanism. SSRIs work indirectly: they increase serotonin availability, and then the brain gradually adapts over weeks. Ketamine directly triggers the molecular cascade (AMPA activation, BDNF release, synaptogenesis) that leads to symptom improvement. The process of building new synaptic connections begins almost immediately after administration.

What the Research Shows

The evidence supporting ketamine for treatment-resistant depression has grown substantially over the past two decades. Response rates in clinical studies generally range from 50 to 70 percent, which is a remarkable figure for a population that, by definition, has already failed multiple treatments. Multiple randomized controlled trials have demonstrated ketamine's superiority over placebo in reducing depressive symptoms, with research published in leading journals including the American Journal of Psychiatry, JAMA Psychiatry, and Biological Psychiatry. Studies show particular effectiveness in reducing suicidal ideation, with some research demonstrating significant reductions within twenty-four hours. A growing body of real-world clinical data supports the findings from controlled trials, and many patients experience meaningful improvement in daily functioning.

It's worth noting that ketamine doesn't work for everyone, and response rates vary across studies depending on dosing protocols, patient populations, and how response is defined. For a treatment being used specifically in patients who haven't responded to anything else, the results represent a genuine advance.

Who Is a Candidate for Ketamine Therapy?

Ketamine therapy for depression is generally considered appropriate for adults with a diagnosis of major depressive disorder or bipolar depression (depressive episodes), a documented failure of at least two adequate antidepressant trials (the standard threshold for treatment-resistant depression, though some providers may consider ketamine after fewer trials in certain circumstances), no active substance use disorders that would contraindicate treatment, no uncontrolled hypertension or significant cardiovascular conditions, no active psychosis or history of psychotic disorders, and medical clearance from a qualified provider.

At Discreet Ketamine, every patient undergoes a comprehensive medical evaluation before treatment begins. The goal is to confirm that ketamine is both safe and appropriate for your specific situation. You can check whether you might be a candidate by visiting our eligibility page.

What to Expect From Treatment

Understanding what the treatment process actually looks like can help reduce anxiety about starting something new.

The treatment protocol

Most protocols involve a series of treatments over two to three weeks to establish a therapeutic response; this initial loading phase is important for building the neuroplastic changes that underlie ketamine's benefits. After the initial series, treatments are typically spaced further apart (weekly, biweekly, or monthly) based on individual response. With Discreet Ketamine, treatments are administered at home under medical supervision and guidance, so you have comfort and privacy during the experience.

During a session

Sessions typically last one to two hours including monitoring time. You may experience altered perceptions, a feeling of floating, or mild dissociation; these effects are temporary and are part of how the treatment works. Most patients describe the experience as calm, introspective, and manageable. You should not drive or operate heavy machinery for the rest of the day after a session.

After treatment

Many patients notice initial improvements in mood, energy, or thought patterns within the first few sessions. The benefits often build and consolidate over the course of the initial treatment series, and ongoing maintenance treatments help sustain the neuroplastic changes.

For a complete walkthrough, see Your First At-Home Ketamine Session: Hour-by-Hour Walkthrough.

Ketamine as Part of a Comprehensive Approach

Ketamine is powerful, but it works best as part of a broader treatment strategy. The neuroplastic window it opens (the period of enhanced synaptic flexibility following treatment) is an ideal time to reinforce positive changes through psychotherapy (particularly CBT or other evidence-based modalities), lifestyle modifications including exercise, sleep hygiene, and stress management, ongoing medical management with your treatment team, and mindfulness and integration practices to process and build on insights from sessions.

Think of ketamine as creating the conditions for change (new neural pathways, restored connectivity, renewed capacity for positive thought patterns), and these complementary approaches as helping to consolidate those changes into lasting recovery.

Why At-Home Treatment Matters

For people with treatment-resistant depression, the logistics of getting to a clinic can be a real barrier. Depression saps motivation, energy, and the ability to manage even basic tasks, let alone scheduling and traveling to repeated appointments.

At-home ketamine therapy through Discreet Ketamine removes that barrier. You receive treatment in your own space, with medical oversight and support from me and our clinical team. This isn't a lesser version of in-clinic treatment. It's a thoughtful adaptation that recognizes the realities of living with severe depression.

Taking the Next Step

If you've tried two or more antidepressants without adequate relief, you're not out of options. You may simply need a treatment that works through a different mechanism. Ketamine's ability to target the glutamate system, promote BDNF-driven neuroplasticity, and deliver rapid symptom relief makes it a scientifically grounded option for treatment-resistant depression.

You don't have to keep waiting for the next SSRI to maybe work. Check your eligibility today and find out if ketamine therapy through Discreet Ketamine might be the different approach your brain has been waiting for.

For the broader picture, see Understanding Treatment-Resistant Depression or the history and science of ketamine therapy.

Frequently Asked Questions

How many antidepressants do you need to fail before ketamine is appropriate?

The standard threshold for "treatment-resistant depression" is failing two or more antidepressants at adequate dose for at least 6 to 8 weeks each. That said, some prescribers consider ketamine after fewer trials when there are clinical reasons (severe depression with active suicidal ideation, intolerable side effects on every SSRI tried, urgent need for response). The two-trial threshold is a clinical convention, not a hard rule. Your physician will weigh your individual treatment history, severity, and risk profile.

Why does ketamine work when SSRIs and SNRIs don't?

Different mechanism. SSRIs and SNRIs work on the serotonin and norepinephrine systems, on the assumption that the depression responds to monoamine modulation. Ketamine works on the glutamate system through NMDA receptor antagonism, which triggers a cascade of BDNF release, mTOR pathway activation, and synaptogenesis. About one in three patients with major depression have neurobiology that doesn't respond well to monoamine modulation; for those patients, reaching a different lever often produces response where serotonin-based drugs cannot.

How fast does ketamine work for treatment-resistant depression?

Most patients notice some shift in mood, anxiety, sleep, or energy within 24 to 72 hours of the first session. Formal rating-scale response (MADRS, HAM-D) typically shows significant reduction at 24 hours in clinical trials. SSRIs by comparison take 4 to 8 weeks. The speed difference comes from mechanism: SSRIs work indirectly by gradually adapting the brain to higher serotonin availability; ketamine directly triggers the molecular cascade that builds new synaptic connections.

What's the response rate for ketamine in treatment-resistant depression?

Clinical studies consistently show response rates (defined as 50 percent or greater reduction in depression symptom scores) in the 50 to 70 percent range for treatment-resistant depression patients. Full remission rates are lower, in the 30 to 50 percent range. Response rates are higher with a complete induction course of 10 or more sessions over 4 to 8 weeks plus integration work, compared to single-session protocols.

Do I need to stop my current antidepressant before starting ketamine?

Almost never. SSRIs and SNRIs are generally safe and complementary to combine with ketamine because they work through completely different mechanisms. Most patients continue their stable antidepressant throughout ketamine treatment. Abruptly stopping risks discontinuation symptoms (dizziness, brain zaps, mood destabilization) that confuse the signal from early ketamine sessions. See our piece on combining ketamine with your SSRI for the specifics.

Will ketamine permanently fix my depression?

Honest answer: usually not from a single course. A typical induction series (10 or more sessions over 4 to 8 weeks) gets most responders into remission or substantial improvement, but the gains tend to need maintenance. Some patients can taper to monthly or quarterly maintenance dosing and hold their gains for years; others stop ketamine entirely after induction and stay well; a smaller subset need continued regular maintenance. Long-term durability depends on how much integration work happens between sessions, lifestyle changes that take, and individual neurobiology.

What if ketamine doesn't work for me either?

About 30 percent of treatment-resistant depression patients don't respond meaningfully to ketamine. If that's you, the next-tier options are TMS (transcranial magnetic stimulation), Spravato (FDA-approved esketamine in clinic settings), ECT (still the gold standard for severe TRD with psychotic features), and emerging next-generation NMDA modulators in clinical trials. Ketamine non-response doesn't mean nothing will work; it means the next intervention should be different again. Your prescribing physician will help you decide what to try.

Is at-home ketamine a real treatment for treatment-resistant depression, or just a convenience play?

It's a real treatment with the same molecule and the same neurobiological mechanism as IV clinic infusions, delivered sublingually at home. Bioavailability is lower (25 to 35 percent vs IV's 100 percent), so doses are adjusted upward to compensate. For maintenance treatment in patients who have already responded, at-home and clinic outcomes look comparable in real-world data. For acute crisis, severe TRD with active suicidality, or patients who need precise minute-by-minute dose titration, IV in a clinic remains the better induction modality.

---

Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary, and ketamine therapy is not appropriate for everyone. Always consult with a qualified healthcare provider before beginning any new treatment. If you are experiencing a mental health crisis, please call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.